Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. (öffnet neues Fenster)

Barillari G, Pasca S, Barillari A, De Angelis V.

Quelle‎: Blood Transfus 2012;10(1):87-94.

Indiziert‎: PubMed 22044952

DOI‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 (öffnet neues Fenster)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (öffnet neues Fenster)

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

Quelle‎: Chest 2012;141(2 Suppl):e326S-50S.

Indiziert‎: PubMed 22315266

DOI‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 (öffnet neues Fenster)

Pharmacological prophylaxis of bleeding in surgical patients treated with aspirin. (öffnet neues Fenster)

Flordal PA.

Quelle‎: Eur J Anaesthesiol Suppl 1997;14:38-41.

Indiziert‎: PubMed 9088834

https://www.ncbi.nlm.nih.gov/pubmed/9088834 (öffnet neues Fenster)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (öffnet neues Fenster)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Quelle‎: Lancet 2015;385(9982):2077-87.

Indiziert‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (öffnet neues Fenster)

How I treat warfarin-associated coagulopathy in patients with intracerebral hemorrhage. (öffnet neues Fenster)

Goodnough LT, Shander A.

Quelle‎: Blood 2011;117(23):6091-9.

Indiziert‎: PubMed 21411756

DOI‎: 10.1182/blood-2010-11-316075

https://www.ncbi.nlm.nih.gov/pubmed/21411756 (öffnet neues Fenster)

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. (öffnet neues Fenster)

Hanke AA, Joch C, Görlinger K.

Quelle‎: Br J Anaesth 2013;110(5):764-72.

Indiziert‎: PubMed 23335567

DOI‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 (öffnet neues Fenster)

Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature. (öffnet neues Fenster)

Jaben EA, Mulay SB, Stubbs JR.

Quelle‎: J Intensive Care Med 2015;30(1):3-7.

Indiziert‎: PubMed 25492811

DOI‎: 10.1177/0885066613487298

https://www.ncbi.nlm.nih.gov/pubmed/25492811 (öffnet neues Fenster)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (öffnet neues Fenster)

Levi M, Eerenberg E, Kamphuisen PW.

Quelle‎: J Thromb Haemost 2011;9(9):1705-12.

Indiziert‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (öffnet neues Fenster)

Emergency reversal of warfarin anticoagulation. (öffnet neues Fenster)

Lin Y, Callum J.

Quelle‎: CMAJ 2010;182(18):2004.

Indiziert‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (öffnet neues Fenster)

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. (öffnet neues Fenster)

Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G.

Quelle‎: Thromb Haemost 2012;108(2):217-24.

Indiziert‎: PubMed 22627883

DOI‎: 10.1160/TH12-03-0179

https://www.ncbi.nlm.nih.gov/pubmed/22627883 (öffnet neues Fenster)

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. (öffnet neues Fenster)

Mo Y, Yam FK.

Quelle‎: Pharmacotherapy 2015;35(2):198-207.

Indiziert‎: PubMed 25644580

DOI‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 (öffnet neues Fenster)

Idarucizumab for dabigatran reversal - full cohort analysis. (öffnet neues Fenster)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Quelle‎: N Engl J Med 2017;377(5):431-41.

Indiziert‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (öffnet neues Fenster)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (öffnet neues Fenster)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Quelle‎: Anesth Analg 2011;113(4):703-10.

Indiziert‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (öffnet neues Fenster)

Oral anticoagulation in surgical procedures: risks and recommendations. (öffnet neues Fenster)

Torn M, Rosendaal FR.

Quelle‎: Br J Haematol 2003;123(4):676-82.

Indiziert‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 (öffnet neues Fenster)

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. (öffnet neues Fenster)

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

Quelle‎: Blood 2012;119(9):2172-4.

Indiziert‎: PubMed 22383791

DOI‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 (öffnet neues Fenster)